Literature DB >> 17513052

Multidimensional Pain Inventory derived classifications of chronic pain: evidence for maladaptive pain-related coping within the dysfunctional group.

Adina C Rusu1, Monika Hasenbring.   

Abstract

This study examines maladaptive pain-related fear-avoidance and endurance coping in subgroups of patients with chronic back pain. Hypotheses were derived from the avoidance-endurance model of pain [Hasenbring M. Attentional control of pain and the process of chronification. In: Sandkühler J, Bromm B, Gebhart GF, editors. Progress in pain research, vol. 129. New York: Elsevier; 2000. p. 525-34.], which assumes that endurance coping (cognitive, behavioral tendency to endure severe pain to finish current activities irrespective of pain increases) leads to overuse of muscles, joints, and discs with an increase of pain as long-term consequence. Participants were 120 patients referred for treatment of chronic pain to General Practices. They were classified as 'dysfunctional-DYS' (15.8%), 'interpersonally distressed-ID' (10.8%), and 'adaptive copers-AC' (61.7%) based on the Multidimensional Pain Inventory [Kerns RD, Turk DC, Rudy TE. The West Haven-Yale Multidimensional Pain Inventory (WHYMPI). Pain 1985;23:345-56.] and compared on measures of pain-related fear-avoidance coping (anxiety/depression; help-/hopelessness; catastrophizing; avoidance of social/physical activity) and endurance coping (positive mood; thought suppression; endurance behavior) using the Kiel Pain Inventory [Hasenbring M. The Kiel Pain Inventory-Manual. Three questionnaire scales for assessment of pain-related cognitions, emotions and copying strategies. Bern:Huber; 1994.]. Multivariate analysis of variance indicated that groups differed significantly for pain-related fear-avoidance and endurance coping, even after control for pain intensity and depression. Univariate effects revealed that patients classified as DYS reported more anxiety/depression, help-/hopelessness, and catastrophizing than did those classified as AC. Furthermore, the DYS group showed more thought suppression compared to AC; however, subgroups did not differ significantly with regard to avoidance of social and physical activity, and endurance behavior. Further, DYS as well as ID group showed more non-verbal pain behavior compared to AC, which refers to the special role of operant conditioning. Implications are considered for further investigation of endurance coping to provide a more comprehensive assessment and treatment for subgroups of chronic pain patients.

Entities:  

Mesh:

Year:  2007        PMID: 17513052     DOI: 10.1016/j.pain.2007.03.031

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  10 in total

1.  [Pilot study on pain response patterns in chronic low back pain. The influence of pain response patterns on quality of life, pain intensity and disability].

Authors:  S L Scholich; D Hallner; R H Wittenberg; A C Rusu; M I Hasenbring
Journal:  Schmerz       Date:  2011-04       Impact factor: 1.107

2.  Healthy and maladaptive dependency and its relationship to pain management and perceptions in physical therapy patients.

Authors:  Steven K Huprich; Patrick Hoban; Ashley Boys; Alexandra Rosen
Journal:  J Clin Psychol Med Settings       Date:  2013-12

3.  [The cortisol awakening response in patients with acute and chronic low back pain. Relations with psychological risk factors of pain chronicity].

Authors:  S Sudhaus; B Fricke; S Schneider; A Stachon; H Klein; M von Düring; M Hasenbring
Journal:  Schmerz       Date:  2007-06       Impact factor: 1.107

4.  The clinical utility of the Multidimensional Pain Inventory (MPI) in characterizing chronic disabling occupational musculoskeletal disorders.

Authors:  YunHee Choi; Tom G Mayer; Mark Williams; Robert J Gatchel
Journal:  J Occup Rehabil       Date:  2013-06

5.  Understanding Pain and Depression in Back Pain: the Role of Catastrophizing, Help-/Hopelessness, and Thought Suppression as Potential Mediators.

Authors:  Janina Hülsebusch; Monika I Hasenbring; Adina C Rusu
Journal:  Int J Behav Med       Date:  2016-06

Review 6.  Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations.

Authors:  Robert R Edwards; Robert H Dworkin; Dennis C Turk; Martin S Angst; Raymond Dionne; Roy Freeman; Per Hansson; Simon Haroutounian; Lars Arendt-Nielsen; Nadine Attal; Ralf Baron; Joanna Brell; Shay Bujanover; Laurie B Burke; Daniel Carr; Amy S Chappell; Penney Cowan; Mila Etropolski; Roger B Fillingim; Jennifer S Gewandter; Nathaniel P Katz; Ernest A Kopecky; John D Markman; George Nomikos; Linda Porter; Bob A Rappaport; Andrew S C Rice; Joseph M Scavone; Joachim Scholz; Lee S Simon; Shannon M Smith; Jeffrey Tobias; Tina Tockarshewsky; Christine Veasley; Mark Versavel; Ajay D Wasan; Warren Wen; David Yarnitsky
Journal:  Pain       Date:  2016-09       Impact factor: 7.926

7.  Fear of movement/(Re)injury in low back pain: confirmatory validation of a German version of the Tampa Scale for Kinesiophobia.

Authors:  Adina Carmen Rusu; Nina Kreddig; Dirk Hallner; Janina Hülsebusch; Monika I Hasenbring
Journal:  BMC Musculoskelet Disord       Date:  2014-08-19       Impact factor: 2.362

8.  Cross-cultural adaptation of the German Pain Solutions Questionnaire: an instrument to measure assimilative and accommodative coping in response to chronic pain.

Authors:  Robert Sielski; Julia Anna Glombiewski; Winfried Rief; Geert Crombez; Antonia Barke
Journal:  J Pain Res       Date:  2017-06-19       Impact factor: 3.133

9.  Impaired Empathic Abilities among Patients with Complex Regional Pain Syndrome (Type I).

Authors:  Hong-Suk Sohn; Do-Hyeong Lee; Kyung-Jun Lee; Eun Chung Noh; Soo-Hee Choi; Joon Hwan Jang; Yong Chul Kim; Do-Hyung Kang
Journal:  Psychiatry Investig       Date:  2015-10-13       Impact factor: 2.505

10.  Behavioral Inhibition and Activation Systems, and Emotional Regulation in Individuals With Chronic Musculoskeletal Pain.

Authors:  Elena R Serrano-Ibáñez; Carmen Ramírez-Maestre; Alicia E López-Martínez; Rosa Esteve; Gema T Ruiz-Párraga; Mark P Jensen
Journal:  Front Psychiatry       Date:  2018-09-10       Impact factor: 4.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.